Skip to content
Home/Companies/MedTech/CorFlow Therapeutics
CT

CorFlow Therapeutics

MedTech·Switzerland·Active·2yr hold

CorFlow Therapeutics is a MedTech company, headquartered in Switzerland.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns CorFlow Therapeutics?

CorFlow Therapeutics is currently owned by Panakes Partners SGR through Panakes Fund Purple (2021 vintage), since 2024.

Hand-verified · updated 2026-07-23

Panakes Partners SGR
Investor
Panakes Partners SGR
Panakes Fund Purple · 2021 · Life Sciences VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive

More from Panakes Fund Purple

Other portfolio companies in the same fund.

Deepull
Active
MedTechSpain· 2025
Endovascular Engineering
Active
MedTechUnited States· 2025
NanoPhoria
Active
BiotechItaly· 2025
Tensive
Active
MedTechItaly· 2025
DISCO Pharmaceuticals
Active
BiotechSwitzerland· 2024
Enterprise Therapeutics
Active
BiotechUnited Kingdom· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
DiappyMed
Active
Irdi Capital-InvestissementFrance· 2026
Hipp Technology Group
Active
Deutsche Beteiligungs AGGermany· 2026
Data refreshed weekly · Sourced from public filings